FDA Approves Velsipity for Moderate-to-Severe Ulcerative Colitis in Adults
TUESDAY, Oct. 17, 2023 (HealthDay News) — The U.S. Food and Drug Administration approved Velsipity (etrasimod) for adults with moderately to severely active ulcerative colitis (UC).The approval was based on results from the ELEVATE UC phase 3 registr…
Learn More5-ASA Discontinuation Common Within First Year of Ulcerative Colitis Diagnosis in Youth
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — For adolescents and young adults diagnosed with ulcerative colitis (UC), the rate of discontinuation of 5-aminosalicylic acid (5-ASA) maintenance treatment is high within the first year, according to a stu…
Learn MoreLower Fiber Intake Tied to Higher Risk for Later Inflammatory Bowel Disease
THURSDAY, Aug. 3, 2023 (HealthDay News) — Higher consumption of dietary fiber was associated with a lower risk for inflammatory bowel disease (IBD), according to a study published online July 18 in Alimentary Pharmacology and Therapeutics.Minzi Deng,…
Learn MoreBelly Fat Can Hamper Effectiveness of Meds for Crohn’s, Colitis
MONDAY, July 31, 2023 (HealthDay News) — Some medications may not treat inflammatory bowel disease (IBD) as effectively if patients carry a lot of excess belly fat, , new research shows. IBD includes illnesses such as Crohn’s disease and ulcerative c…
Learn MoreNew Drug Could Boost Outcomes for People With Ulcerative Colitis
TUESDAY, July 18, 2023 (HealthDay News) — People living with the pain, bloody diarrhea and sometimes urgent need to use the toilet that comes with ulcerative colitis may soon have a new treatment option that’s already been given the go-ahead in Europ…
Learn MoreMirikizumab Tops Placebo for Moderately-to-Severely Active Ulcerative Colitis
FRIDAY, July 7, 2023 (HealthDay News) — For patients with moderately-to-severely active ulcerative colitis, mirikizumab is more effective than placebo for inducing and maintaining clinical remission, according to a study published in the June 29 issu…
Learn MoreInflammatory Bowel Disease Tied to Higher Odds for Stroke
THURSDAY, June 15, 2023 (HealthDay News) — Having inflammatory bowel disease, or IBD, could mean having a higher long-term risk of stroke, according to a new study.People with IBD are 13% more likely to have a stroke up to 25 years after their diagno…
Learn MoreInflammatory Bowel Disease Tied to Higher Odds for Stroke
THURSDAY, June 15, 2023 (HealthDay News) — Having inflammatory bowel disease, or IBD, could mean having a higher long-term risk of stroke, according to a new study.People with IBD are 13% more likely to have a stroke up to 25 years after their diagno…
Learn MoreSmall Increase in Lymphoma Risk Seen With Crohn Disease, Ulcerative Colitis
WEDNESDAY, May 10, 2023 (HealthDay News) — Crohn disease (CD) and ulcerative colitis (UC) are associated with a slightly increased risk for lymphoma, according to a study published online April 13 in Clinical Gastroenterology and Hepatology.Ola Olén …
Learn MoreVedolizumab Aids Remission in Chronic Pouchitis After Ileal Pouch-Anal Anastomosis
FRIDAY, March 31, 2023 (HealthDay News) — For patients with chronic pouchitis after undergoing restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for ulcerative colitis, treatment with vedolizumab is more effective than placebo for …
Learn More